Dr. Pennell on Emerging Molecular Markers in NSCLC Management: Podcast Now Available


   We know that many people interested in the topics we discuss in our webinars may not be able to attend the live programs, but we’re committed to offering our content to people as easily as possible.   Accordingly, here is the podcast version of Dr. Pennell’s very well received presentation on a range of molecular markers currently being used and others emerging in clinical trials as potential tools for the coming years. 

   Below you’ll find the audio and video versions of the presentation, along with a transcript and a pdf file of the figures that go with the transcript.

dr-pennell-webinar-molecular-markers-audio-podcast

dr-pennell-webinar-molecular-markers-transcript

dr-pennell-webinar-molecular-markers-figures

   This program was sponsored by an educational grant from Response Genetics, though Response Genetics had no input in the program content.

   There was also a question and answer session after his presentation, and that will be offered as a separate podcast recording soon.

   For those of you who are interested in being part of the audience of our next live webinar presentation (also with Dr. Pennell), it’s coming up next week, Tuesday evening at 8 PM EST/5 PM PST, and you can register with this link.

Related posts:

    Podcast of Webinar by Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors A few weeks ago, Dr. Lecia Sequist, Assistant Professor of Medicine at Harvard Medica...

    Upcoming Webinar on Molecular Markers in Advanced NSCLC: Who to Test and What to Test For? On Feb 22nd, 6:30 PM Eastern/3:30 PM Pacific, GRACE and LUNGevity Foundation wil...

    Dr. Ross Camidge on ALK Inhibition, Molecular Screening, and Options after XALKORI Continuing with Dr. Ross Camidge as our focus (see yesterday’s post for ...

    First ASCO Highlights Podcast: Dr. Pinder on Small Cell, Early Stage NSCLC, and Mesothelioma Several weeks ago, we were fortunate enough to have Dr. Mary Pinder (alternatel...

    ASCO Highlights in Advanced NSCLC, by Dr. Nasser Hanna Here’s the second talk from our recent webinar, partnering with LUNGevit...

Posted in: EGFR mutations and other molecular markers, Epidermal growth factor receptor (EGFR)-based therapies, First-line treatment, GRACEcast, Second-line treatment, Stage IV/Advanced/Metastatic NSCLC, Targeted Therapies, Activity and Side Effects, Targeted therapies, Treatment, Webinars, never-smoker NSCLC

1 Comment  

Article on Molecularly Based Treatments for Lung Cancer in CURE Magazine | GRACE :: Lung Cancer
Posted on March 25, 2010 at 1:11 pm

[...] line of work.  For those interested in learning more, I’d highly recommend you check out his excellent GRACE webinar on the emerging role of molecular markers in NSCLC, as well as the GRACE webinar by Dr. Ross Camidge from the University of Colorado on “Moving [...]